← Leaderboards
Shannon L McKinney-Freeman
Boston Children'S Hospital
$6,852,518
Attributed
$6,852,518
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $958.8K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,852,518 · 6
By mechanism
R01$5,743,627 · 3
K01$771,140 · 1
T32$250,251 · 1
R03$87,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Teresa V Bowman$4,999,652
- Ben Adam Croker$3,608,646
- Daniel Evan Bauer$19,160,492
- Kitai Kim$3,211,318
- Owen James Tamplin$4,679,872
Others in their field
Top investigators on “Bone Marrow”
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- J. Mark Cline · Wake Forest University$31,844,583
Research focus
Bone MarrowCellsIn VivoHematopoietic Stem CellsTransplantationGenesLaboratoriesLifeGene ExpressionBone Marrow TransplantationPhenotypeProgenitorHematopoieticEmbryoMolecularBloodHematological DiseaseApoptosisPostdoctoral FellowErythroidHematopoietic Stem Cell TransplantationLeukemiaHematopoiesisCell Surface
Grant awards (21)
Investigating hematopoietic stem cell dysfunction during sickle cell disease$708,579
R01 · FY2025 · HL · contact PI
Basic and Translational Research Training in Pediatric Classical Hematology$250,251
T32 · FY2025 · HL · contact PI
Investigating hematopoietic stem cell dysfunction during sickle cell disease$694,406
R01 · FY2024 · HL · contact PI
Investigating hematopoietic stem cell dysfunction during sickle cell disease$708,579
R01 · FY2023 · HL · contact PI
Improving HSC transplantation by defining novel regulators of engraftment$403,875
R01 · FY2022 · DK · contact PI
Improving HSC transplantation by defining novel regulators of engraftment$403,875
R01 · FY2021 · DK · contact PI
Improving HSC transplantation by defining novel regulators of engraftment$403,875
R01 · FY2020 · DK · contact PI
Defining Nfix's role as a novel key regulator of hematopoietic stem cells$403,875
R01 · FY2020 · DK · contact PI
Improving HSC transplantation by defining novel regulators of engraftment$403,875
R01 · FY2019 · DK · contact PI
Defining Nfix's role as a novel key regulator of hematopoietic stem cells$403,875
R01 · FY2019 · DK · contact PI
Defining Nfix's role as a novel key regulator of hematopoietic stem cells$403,875
R01 · FY2018 · DK · contact PI
Defining Nfix's role as a novel key regulator of hematopoietic stem cells$403,875
R01 · FY2017 · DK · contact PI
Defining Nfix's role as a novel key regulator of hematopoietic stem cells$401,063
R01 · FY2016 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$146,340
K01 · FY2012 · DK · contact PI
Functional study of novel transcriptional regulators of hematopoietic stem cells$87,500
R03 · FY2012 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$146,340
K01 · FY2011 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$86,400
K01 · FY2010 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$59,900
K01 · FY2010 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$53,520
K01 · FY2010 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$139,320
K01 · FY2009 · DK · contact PI
Characterization of embryonic stem cell-derived hematopoietic stem cells$139,320
K01 · FY2008 · DK · contact PI